Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Protein Sci. 2024 May;33(5):e4994. doi: 10.1002/pro.4994.
Sirtuin 2 (SIRT2) is a class III histone deacetylase that is highly conserved from bacteria to mammals. We prepared and characterized the wild-type (WT) and mutant forms of the histone deacetylase (HDAC) domain of human SIRT2 (hSIRT2) using various biophysical methods and evaluated their deacetylation activity. We found that WT hSIRT2 HDAC (residues 52-357) forms a homodimer in a concentration-dependent manner with a dimer-monomer dissociation constant of 8.3 ± 0.5 μM, which was determined by mass spectrometry. The dimer was disrupted into two monomers by binding to the HDAC inhibitors SirReal1 and SirReal2. We also confirmed dimer formation of hSIRT2 HDAC in living cells using a NanoLuc complementation reporter system. Examination of the relationship between dimer formation and deacetylation activity using several mutants of hSIRT2 HDAC revealed that some non-dimerizing mutants exhibited deacetylation activity for the N-terminal peptide of histone H3, similar to the wild type. The hSIRT2 HDAC mutant Δ292-306, which lacks a SIRT2-specific disordered loop region, was identified to exist as a monomer with slightly reduced deacetylation activity; the X-ray structure of the mutant Δ292-306 was almost identical to that of the WT hSIRT2 HDAC bound to an inhibitor. These results indicate that hSIRT2 HDAC forms a dimer, but this is independent of deacetylation activity. Herein, we discuss insights into the dimer formation of hSIRT2 based on our biophysical experimental results.
Sirtuin 2 (SIRT2) 是一种 III 类组蛋白去乙酰化酶,从细菌到哺乳动物都高度保守。我们使用各种生物物理方法制备和表征了人 SIRT2(hSIRT2)的组蛋白去乙酰化酶(HDAC)结构域的野生型(WT)和突变体形式,并评估了它们的去乙酰化活性。我们发现 WT hSIRT2 HDAC(残基 52-357)以浓度依赖的方式形成同源二聚体,二聚体-单体解离常数为 8.3±0.5μM,这是通过质谱法确定的。二聚体通过与 HDAC 抑制剂 SirReal1 和 SirReal2 结合而解聚成两个单体。我们还使用 NanoLuc 互补报告系统在活细胞中证实了 hSIRT2 HDAC 的二聚体形成。使用 hSIRT2 HDAC 的几种突变体检查二聚体形成与去乙酰化活性之间的关系表明,一些不能形成二聚体的突变体表现出与野生型相似的组蛋白 H3 N 端肽的去乙酰化活性。缺乏 SIRT2 特异性无规卷曲环区域的 hSIRT2 HDAC 突变体 Δ292-306 被鉴定为单体存在,去乙酰化活性略有降低;突变体 Δ292-306 的 X 射线结构几乎与与抑制剂结合的 WT hSIRT2 HDAC 的结构相同。这些结果表明 hSIRT2 HDAC 形成二聚体,但这与去乙酰化活性无关。在此,我们根据我们的生物物理实验结果讨论了对 hSIRT2 二聚体形成的深入了解。